CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited

1:15-cv-00921

Overview

Case Number 1:15-cv-00921
Filing Date 2015-10-13
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Inventia Healthcare Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Inventia Healthcare Pvt. Ltd. Operating Company

Represented By

2 Attorneys Listed

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Counter Defendant

Vanda Pharmaceuticals Inc. Operating Company

Represented By

9 Attorneys Listed

Daniel J. Klein

Email: dan.klein@groombridgewu.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Nicholas Groombridge

Email: Nick.groombridge@groombridgewu.com

Ethan Haller Townsend

McDermott Will & Emery LLP

Tel: +1 (302) 485-3900

4th floor, The Brandywine Building

Karen Jacobs

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Kira A. Davis

Email: kiradavis@mofo.com

Eric A. Stone

Email: estone@paulweiss.com

Josephine Young

Email: josephine.young@groombridgewu.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9138432
Methods for the administration of iloperidone
Filed: 2014-01-08
Issued: 2015-09-22
Active (7.1 yrs remaining)
Expires: 2034-01-08
US8586610
Methods for the administration of iloperidone
Filed: 2005-09-30
Issued: 2013-11-19
Active (1.0 yrs remaining) +763d PTA
Expires: 2027-11-02

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

32

Dispositive

0

Granted

0

Denied

0

Pending / Review

21

Motions by Category

Procedural / Extension Motion 31 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #213 • 2025-09-22 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #209 • 2025-08-11 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #205 • 2025-07-07 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #201 • 2025-06-10 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #196 • 2025-03-04 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #191 • 2025-01-07 Document →

Docket Entries

(297 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Inventia Healthcare Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806836) - filed by Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Inventia Healthcare Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806836) - filed by Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Inventia Healthcare Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806836) - filed by Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 10/14/2015)

Entry #2 • 2015-10-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 9/30/2025. (sar) (Entered: 10/14/2015)

Entry #3 • 2015-10-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc